Peter Zerhouni steps down as CEO of InDex Pharmaceuticals
April 11, 2022 – InDex Pharmaceuticals Holding AB (publ) today announced that after more than seven years as CEO, Peter Zerhouni has decided to leave his position. The company’s CFO Johan Giléus has been appointed acting CEO while a new CEO is being recruited, and he will also continue as CFO.“With the drug candidate cobitolimod in phase III, a clear plan to market, and a solid financial position, InDex stands stronger than ever,” said Wenche Rolfsen, chairman of InDex Pharmaceuticals. “I want to thank Peter for his contribution in building the company and for his good collaboration. I wish